{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:11:11Z","timestamp":1787015471815,"version":"build-2736575974"},"reference-count":18,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Current treatment guidelines for early stages of syphilis are the same regardless of\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      serostatus. There is still controversy about the best treatment for syphilis in\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      patients and the current recommendations are based on limited data.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      The primary goal of this study was to compare the serological response rates to a single dose\n                      <jats:bold>vs.<\/jats:bold>\n                      three weekly doses of benzathine penicillin G (\n                      <jats:styled-content style=\"fixed-case\">BPG<\/jats:styled-content>\n                      ) in\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      \u2010infected patients with early syphilis and to assess the adequacy of current recommendations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Clinical and laboratory data of\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      patients with early syphilis treated in Sexually Transmitted Disease Clinic between January 2000 and December 2014 were recorded. A good serological response was defined as a \u22654\u2010fold decline in Venereal Disease Research Laboratory (\n                      <jats:styled-content style=\"fixed-case\">VDRL<\/jats:styled-content>\n                      ) titre within 12 months after treatment. Serological failure was defined as a lack of at least fourfold decrease in\n                      <jats:styled-content style=\"fixed-case\">VDRL<\/jats:styled-content>\n                      titres within 12 months after treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After applying inclusion and exclusion criteria, 60 patients were enrolled in the study. Seventeen (28.3%) patients were treated with a single dose of\n                      <jats:styled-content style=\"fixed-case\">BPG<\/jats:styled-content>\n                      , while in 43 (71.7%) patients, three weekly doses were used. Fifty eight (96.7%) had a good serological response at 12 months and seroconversion was confirmed in 29 (48.3%) patients. There was no statistically significant difference between the two treatment groups regarding serological response, seroconversion rate and the time needed to obtain a good serological response. Furthermore, treatment response was not affected by the number of\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      <jats:sub>4<\/jats:sub>\n                      cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The results of our study support the current international treatment guidelines, recommending early syphilis treatment with a single dose of\n                      <jats:styled-content style=\"fixed-case\">BPG<\/jats:styled-content>\n                      in\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jdv.13766","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T01:35:07Z","timestamp":1466645707000},"page":"1805-1809","source":"Crossref","is-referenced-by-count":11,"title":["Early syphilis treatment in\n                    <scp>HIV<\/scp>\n                    \u2010infected patients: single dose vs. three doses of benzathine penicillin G"],"prefix":"10.1111","volume":"30","author":[{"given":"M.","family":"Costa\u2010Silva","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology Centro Hospitalar S\u00e3o Jo\u00e3o, EPE Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Azevedo","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Centro Hospitalar S\u00e3o Jo\u00e3o, EPE Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Azevedo","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology Centro Hospitalar S\u00e3o Jo\u00e3o, EPE Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lisboa","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology Centro Hospitalar S\u00e3o Jo\u00e3o, EPE Porto Portugal"},{"name":"Department of Microbiology Faculty of Medicine University of Porto Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,22]]},"reference":[{"key":"e_1_2_5_2_1","unstructured":"European Centre for Disease Prevention and Control. Annual Epidemiological Report 2013.Reporting on 2011 surveillance data and 2012 epidemic intelligence dataStockholm: ECDC2013.http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/annual-epidemiological-report-2013.pdf(last accessed 5 January 2015)."},{"key":"e_1_2_5_3_1","first-page":"34","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski KA","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2008.008279"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12734"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1086\/644737"},{"key":"e_1_2_5_7_1","first-page":"54","article-title":"Dilemmas in the management of syphilis","volume":"106","author":"Muldoon E","year":"2013","journal-title":"Ir Med J"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2010.043893"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-11-872"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir701"},{"key":"e_1_2_5_11_1","unstructured":"European Centre for Disease Prevention and Control. STD Surveillance case definitions.http:\/\/www.ecdc.europa.eu\/en\/activities\/surveillance\/sti\/Pages\/Case%20definition.aspx(last accessed 5 January 2015)."},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-605"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707313370504"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1258\/095646207782717018"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu888"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109667"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.15.6.18106"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis757"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2006.021402"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.13766","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.13766","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.13766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T08:12:16Z","timestamp":1695456736000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.13766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,22]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1111\/jdv.13766"],"URL":"https:\/\/doi.org\/10.1111\/jdv.13766","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,22]]}}}